A broad-spectrum inhibitory peptide against staphylococcal enterotoxin superantigen SEA, SEB and SEC

Immunology Letters

Volumn 121, Issue 2, 2008, Pages 167-172

  Wang, Sixiong ^a   Li, Yafei ^a   Xiong, Hongyan ^a   Cao, Jia ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Antagonist peptide; Septic shock; Staphylococcal enterotoxin; Superantigen

Indexed keywords

AMINO ACID; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEPTIDE; PEPTIDE P72; STAPHYLOCOCCUS ENTEROTOXIN A; STAPHYLOCOCCUS ENTEROTOXIN B; STAPHYLOCOCCUS ENTEROTOXIN C; SUPERANTIGEN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX; MAJOR HISTOCOMPATIBILITY COMPLEX CLASS II; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SEPTIC SHOCK; TOXIN STRUCTURE;

AMINO ACID MOTIFS; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; ENTEROTOXINS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; LEUKOCYTES, MONONUCLEAR; PEPTIDES; PROTEIN BINDING; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SHOCK, SEPTIC; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SUPERANTIGENS;

EID: 57449087201     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2008.10.007     Document Type: Article

References (21)

1. Li Y., Zhu X., Huang Y., and Xiong H. Mutational analysis of the binding of staphylococcal enterotoxin D to the T cell receptor Vbeta chain and major histocompatibility complex class II. Immunol Lett 105 (2006) 55-60
2. Marrack P., Blackman M., Kushnir E., and Kappler J. The toxicity of staphylococcal enterotoxin B in mice is mediated by T cells. J Exp Med 171 (1990) 455-464
3. Hackett S.P., and Stevens D.L. Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-b synthesis. J Infect Dis 168 (1993) 232-235
4. Dinges M.M., Orwin P.M., and Schlievert P.M. Exotoxins of staphylococcus aureus. Clin Microbiol Rev 13 (2000) 16-34
5. Orwin P.M., Leung D.Y., Donahue H.L., Novick R.P., and Schlievert P.M. Biochemical and biological properties of staphylococcal enterotoxin K. Infect Immun 69 (2001) 360-366
6. Orwin P.M., Fitzgerald J.R., Leung D.Y., Gutierrez J.A., Bohach G.A., and Schlievert P.M. Characterization of staphylococcus aureus enterotoxin L. Infect Immun 71 (2003) 2916-2919
7. Omoe K., Hu D.L., Takahashi-Omoe H., Nakane A., and Shinagawa K. Identification and characterization of a new staphylococcal enterotoxinrelated putative toxin encoded by two kinds of plasmids. Infect Immun 71 (2003) 6088-6094
8. Alouf J.E., and Müller-Alouf H. Staphylococcal and streptococcal superantigens: molecular, biological and clinical aspects. Int J Med Microbiol 292 (2003) 429-440
9. Fluer F.S. Staphylococcal toxin of toxic shock syndrome. Zh Mikrobiol Epidemiol Immunobiol (September-October, 2007) 106-114
10. Hussain A., Robinson G., Malkin J., Duthie M., Kearns A., and Perera N. Purpura fulminans in a child secondary to Panton-Valentine leukocidin-producing staphylococcus aureus. J Med Microbiol 56 (2007) 1407-1409
11. Yarwood J.M., Leung D.Y., and Schlievert P.M. Evidence for the involvement of bacterial superantigens in psoriasis, atopic dermatitis, and Kawasaki syndrome. FEMS Microbiol Lett 192 (2000) 1-7
12. Tervaert J.W., Popa E.R., and Bos N.A. The role of superantigens in vasculitis. Curr Opin Rheumatol 11 (1999) 24-33
13. Bunikowski R., Mielke M.E., Skarabis H., Worm M., Anagnostopoulos I., Kolde G., et al. Evidence for a disease-promoting effect of staphylococcus aureus-derived exotoxins in atopic dermatitis. J Allergy Clin Immunol 105 (2000) 814-819
14. Bachert C., Zhang N., Patou J., van Zele T., and Gevaert P. Role of staphylococcal superantigens in upper airway disease. Curr Opin Allergy Clin Immunol 8 (2008) 34-38
15. Herman A., Kappler J.W., Marrack P., and Pullen A.M. Superantigens: mechanism of T-cell stimulation and role in immune responses. Annu Rev Immunol 9 (1991) 745-772
16. Arad G., Hillman D., Levy R., and Kaempfer R. Broad-spectrum immunity against superantigens is elicited in mice protected from lethal shock by a superantigen antagonist peptide. Immunol Lett 91 (2004) 141-145
17. Visvanathan K., Charles A., Bannan J., Pugach P., Kashfi K., and Zabriskie J.B. Inhibition of bacterial superantigens by peptides and antibodies. Infect Immun 69 (2001) 875-884
18. Arad G., Levy R., Hillman D., and Kaempfer R. Superantigen antagonist protects against lethal shock and defines a new domain for T-cell activation. Nat Med 6 (2000) 414-421
19. Arcus V.L., Proft T., Sigrell J.A., Baker H.M., Fraser J.D., and Baker E.N. Conservation and variation in superantigen structure and activity highlighted by the three-dimensional structures of two new superantigens from Streptococcus pyogenes. J Mol Biol 299 (2000) 157-168
20. Arad G., Hillman D., Levy R., and Kaempfer R. Superantigen antagonist blocks Th1 cytokine gene induction and lethal shock. J Leukoc Biol 69 (2001) 921-927
21. Kaempfer R. Peptide antagonists of superantigen toxins. Mol Divers 8 (2004) 113-120